George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 110,000 shares at $39.77 ($4.4M) on 2025-12-03, disclosed to the SEC on 2025-12-05.
Scheduled sale ($4.4M) by EVP, Investments & CLO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |
| RPRX | SELL | 2023-02-27 | $1.9M | — | Filing → |